Description
There is no detailed description, see related
Used in the treatment of
- Y49.3 Adverse effects in therapeutic use, phenothiazine antipsychotics and neuroleptics
- Y49.4 Adverse effects in therapeutic use, butyrophenone and thioxanthene neuroleptics
- Y49.5 Adverse effects in therapeutic use, other antipsychotics and neuroleptics
- Y88.0 Sequelae of adverse effects caused by drugs, medicaments and biological substances in therapeutic use
- R25.8.0* Hyperkinesis
- F95 Tic disorders
- G20 Parkinson's disease
- G21 Secondary parkinsonism
- G21.1 Other drug-induced secondary parkinsonism
- G21.3 Postencephalitic parkinsonism
- G24 Dystonia
- G24.0 Drug-induced dystonia
- G24.1 Idiopathic familial dystonia
- G24.9 Dystonia, unspecified
- G25 Other extrapyramidal and movement disorders
- G25.1 Drug-induced tremor
- G25.3 Myoclonus
- G25.6 Drug-induced tics and other tics of organic origin
- G40.9 Epilepsy, unspecified
- G83 Other paralytic syndromes
- H40.2 Primary angle-closure glaucoma
- I49.9 Cardiac arrhythmia, unspecified
- K56 Paralytic ileus and intestinal obstruction without hernia
- K59.3 Megacolon, not elsewhere classified
- N40 Hyperplasia of prostate
- R25.1 Tremor, unspecified
- R25.2 Cramp and spasm
- R29.8 Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
- R39.1 Other difficulties with micturition
- T43.3 Poisoning, phenothiazine antipsychotics and neuroleptics
- T60.0 Toxic effect, organophosphate and carbamate insecticides
- T65.2 Toxic effect, tobacco and nicotine